Search | IOVS | ARVO Journals

Showing 1 – 20 of 21

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Greater reduction in hard exudates with faricimab vs aflibercept in patients with DME: biomarker results from the phase 3 YOSEMITE/RHINE trials

Roger A. Goldberg; Manuel Amador; Christiana Dinah; Kara Gibson; Carl G O Glittenberg; Andreas Maunz; Olivia O’Leary; Ehsan Rahimy; Diane Uschner

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6228.

ARVO Annual Meeting Abstract June 2024

Efficacy and Safety of Faricimab in ALTIMETER: A Trial Exploring Biomarkers of Ang-2 Inhibition in Patients With DME

Sabin Dang; Manuel Amador; Andreas Dieckmann; Kara Gibson; Carl G O Glittenberg; Alex Kotak; Florie Mar; Audrey Souverain; Bjoern Titz; Stela Vujosevic; Amani Fawzi

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6235.

ARVO Annual Meeting Abstract June 2024

Faricimab treatment outcomes with extended dosing and potential for Q20W intervals in DME: post hoc analysis of the 96-week phase 3 YOSEMITE/RHINE trials

Murtaza K Adam; Kara Gibson; Dawn Sim; Manuel Amador; Lauren Hill; Michael Singer

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1756.

ARVO Annual Meeting Abstract June 2024

Key clinical and anatomic outcomes from the YOSEMITE/RHINE trials of faricimab in patients with DME.

Niranjan Manoharan; Manuel Amador; Jeffrey Willis; Francis Abreu; Ivo Stoilov; Florie Mar; Kara Gibson

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6239.

ARVO Annual Meeting Abstract June 2024

Elevatum study design and rationale: a phase 4 trial of faricimab (VABYSMO) in underrepresented patients with DME

Jeremiah Brown; Matthew Cunningham; Joseph M Coney; Adrienne Scott; Manuel Amador; Jennifer Chang; Ming Yang; Ivo Stoilov; Luis Gonzalez

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6242.

ARVO Annual Meeting Abstract June 2024

Clinical pearls from the TENAYA/LUCERNE trials of faricimab in patients with nAMD

Sara Haug; Manuel Amador; Aachal Kotecha; Philippe Margaron; Ivo Stoilov; Yannan Tang

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5696.

ARVO Annual Meeting Abstract June 2024

Retinal vasculitis with or without retinal vascular occlusion among eyes with nAMD or DME treated with IVT agents as recorded in the Vestrum database

Shriji Patel; Gloria Chi; Vaibhavi Patel; Nick Boucher; Nitika Aggarwal; Shih-Chen Chang; Sumit Sharma; Manuel Amador; Marco A Zarbin

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5672.

ARVO Annual Meeting Abstract June 2023

Faricimab reduces macular leakage vs aflibercept in patients with DME

Roger A. Goldberg; Anton Kolomeyer; Eric Nudleman; Karl Csaky; Jeffrey Willis; Kara Gibson; Tracey Wang; Zdenka Haskova; Eugene Shildkrot; Manuel Amador; Florie Mar

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2816.

ARVO Annual Meeting Abstract June 2022

Subretinal fibrosis in patients with choroidal neovascularization based on spectral-domain optical coherence tomography classification: findings from the HARBOR trial

Sean Adrean; Lauren Hill; Manuel J Amador-Patarroyo

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3869.

Special Issue October 2020

Artificial Intelligence for Automated Overlay of Fundus Camera and Scanning Laser Ophthalmoscope Images

PDF

Melina Cavichini; Cheolhong An; Dirk-Uwe G. Bartsch; Mahima Jhingan; Manuel J. Amador-Patarroyo; Christopher P. Long; Junkang Zhang; Yiqian Wang; Alison X. Chan; Samantha Madala; Truong Nguyen; William R. Freeman
TAGS: artificial intelligence, lasers, ophthalmoscopes, scanning laser ophthalmoscopy, diagnostic imaging
Trans. Vis. Sci. Tech.. 2020; 9(2):56. https://doi.org/10.1167/tvst.9.2.56

ARVO Annual Meeting Abstract June 2020

Choroidal biomarkers to predict long term remission and poor response with standardized anti-vascular endothelial growth factor regimen

Mahima Jhingan; Melina Cavichini Cordeiro; Kunny Dans; Manuel Amador; Dirk-Uwe G Bartsch; Jay Chhablani; William R Freeman

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2640.

ARVO Annual Meeting Abstract July 2019

Factors Associated with Extended Remission in Neovascular Age-Related Macular Degeneration on Pro Re Nata Treatment Protocol

Tiezhu Lin; Kunny Dans; Ilkay Kilic Muftuoglu; Amit Meshi; Manuel Amador; Lingyun Cheng; William R Freeman

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):74.

ARVO Annual Meeting Abstract July 2019

Confusion Matrix Evaluation of the Clinical Utility of OCT Angiography in AMD-associated Choroidal Neovascularization

Melina Cavichini Cordeiro; Kunny Dans; Mahima Jhingan; Manuel Amador; Dirk-Uwe G Bartsch; Eric Nudleman; William R Freeman

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3004.

ARVO Annual Meeting Abstract July 2019

High-Dose High-Frequency Aflibercept For Recalcitrant Neovascular Age-Related Macular Degeneration (2-year follow up)

Manuel Amador; Mahima Jhingan; Amit Meshi; Kunny Dans; Tiezhu Lin; Melina Cavichini Cordeiro; William R Freeman

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):112.

ARVO Annual Meeting Abstract July 2019

Choroidal vascularity index in myopia

Mahima Jhingan; Kunny Dans; Melina Cavichini Cordeiro; Dirk-Uwe G Bartsch; Manuel Amador; Jay Chhablani; William R Freeman

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1544.

ARVO Annual Meeting Abstract July 2019

Comparison of High Magnification Module for Spectralis to Adaptive Optics Scanning Laser Ophthalmoscopy

Dirk-Uwe G Bartsch; Manuel Amador; Kunny Dans; Mahima Jhingan; Melina Cavichini Cordeiro; William R Freeman

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1424.

ARVO Annual Meeting Abstract July 2018

Effect of Fasting and Food Ingestion On Quality of Oral Fluorescein Angiography

Manuel Amador; Amit Meshi; Tiezhu Lin; Kunny C Dans; Kevin Chen; William R Freeman

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1508.

ARVO Annual Meeting Abstract July 2018

Improvements to manual registration of AOSLO image sequences

Dirk-Uwe G Bartsch; Manuel Amador; Amit Meshi; Kunny C Dans; Tiezhu Lin; William R Freeman

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):660.

ARVO Annual Meeting Abstract July 2018

Comparison of retinal pathology visualization in multi-spectral scanning laser imaging

Amit Meshi; Tiezhu Lin; Kunny Dans; Manuel Amador; Kevin Chen; Kyle Hasenstab; Ilkay Muftuoglu; Eric Nudleman; Daniel Chao; Dirk-Uwe G Bartsch; William R Freeman

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1501.

ARVO Annual Meeting Abstract July 2018

Acute symptomatic posterior vitreous detachments do not adversely affect contrast sensitivity

Kunny C Dans; Daniel Chao; Amit Meshi; Tiezhu Lin; Manuel Amador; Shyamanga Borooah; Kevin Chen; Maria Laura Gomez; Dirk-Uwe G Bartsch; Eric Nudleman; William R Freeman

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1846.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Greater reduction in hard exudates with faricimab vs aflibercept in patients with DME: biomarker results from the phase 3 YOSEMITE/RHINE trials

Efficacy and Safety of Faricimab in ALTIMETER: A Trial Exploring Biomarkers of Ang-2 Inhibition in Patients With DME

Faricimab treatment outcomes with extended dosing and potential for Q20W intervals in DME: post hoc analysis of the 96-week phase 3 YOSEMITE/RHINE trials

Key clinical and anatomic outcomes from the YOSEMITE/RHINE trials of faricimab in patients with DME.

Elevatum study design and rationale: a phase 4 trial of faricimab (VABYSMO) in underrepresented patients with DME

Clinical pearls from the TENAYA/LUCERNE trials of faricimab in patients with nAMD

Retinal vasculitis with or without retinal vascular occlusion among eyes with nAMD or DME treated with IVT agents as recorded in the Vestrum database

Faricimab reduces macular leakage vs aflibercept in patients with DME

Subretinal fibrosis in patients with choroidal neovascularization based on spectral-domain optical coherence tomography classification: findings from the HARBOR trial

Artificial Intelligence for Automated Overlay of Fundus Camera and Scanning Laser Ophthalmoscope Images

Choroidal biomarkers to predict long term remission and poor response with standardized anti-vascular endothelial growth factor regimen

Factors Associated with Extended Remission in Neovascular Age-Related Macular Degeneration on Pro Re Nata Treatment Protocol

Confusion Matrix Evaluation of the Clinical Utility of OCT Angiography in AMD-associated Choroidal Neovascularization

High-Dose High-Frequency Aflibercept For Recalcitrant Neovascular Age-Related Macular Degeneration (2-year follow up)

Choroidal vascularity index in myopia

Comparison of High Magnification Module for Spectralis to Adaptive Optics Scanning Laser Ophthalmoscopy

Effect of Fasting and Food Ingestion On Quality of Oral Fluorescein Angiography

Improvements to manual registration of AOSLO image sequences

Comparison of retinal pathology visualization in multi-spectral scanning laser imaging

Acute symptomatic posterior vitreous detachments do not adversely affect contrast sensitivity

To View More...

You must be signed into an individual account to use this feature.